Clearside Biomedical Inc (CLSD) stock is higher by 43.02% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives CLSD stock a score of 66 out of a possible 100.
That rank is influenced by a fundamental score of 98. In addition to the average rating from Wall Street analysts, CLSD stock has a mean target price of 5.833. This means analysts expect the stock to rise 127.85% over the next 12 months. CLSD's rank also includes a short-term technical score of 70. The long-term technical score for CLSD is 32.
What's Happening with CLSD Stock Today
Clearside Biomedical Inc (CLSD) stock is down -8.24% while the S&P 500 is higher by 0.19% as of 2:11 PM on Tuesday, Apr 13. CLSD is lower by -$0.23 from the previous closing price of $2.79 on volume of 200,167 shares. Over the past year the S&P 500 has gained 49.77% while CLSD is higher by 43.02%. CLSD lost -$0.39 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Clearside Biomedical Inc (CLSD) Stock.
